Overview

Duloxetine Versus Placebo for Fibromyalgia

Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine if duloxetine reduces pain severity in patients with fibromyalgia.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Duloxetine Hydrochloride